Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature

Liver Transplantation

Volumn 18, Issue 2, 2012, Pages 201-205

  Campos Varela, Isabel ^a,c,d   Castells, Lluís ^a,c,d   Dopazo, Cristina ^a   Pérez Lafuente, Mercedes ^b   Allende, Helena ^b   Len, Oscar ^b   Llopart, Lluís ^b   Vargas, Victor ^a,c,d   Charco, Ramõn ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; EMTRICITABINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RALTEGRAVIR; RAPAMYCIN; STEROID; TACROLIMUS; TENOFOVIR;

ADULT; ALCOHOL ABUSE; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; END STAGE LIVER DISEASE; GRAFT RECIPIENT; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SINUSOIDAL OBSTRUCTION SYNDROME; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRASOUND; VIRUS LOAD;

ASCITES; BIOPSY; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHLEBOGRAPHY; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RADIOGRAPHY, INTERVENTIONAL; TREATMENT OUTCOME;

EID: 84856295928     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22351     Document Type: Article

References (28)

1. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED,. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122. (Pubitemid 14185436)
2. Bearman SI,. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
3. Richardson P, Guinan E,. The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches. Br J Haematol 1999; 107: 485-493.
4. Bras G, Jelliffe DB, Stuart KL,. Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica. AMA Arch Pathol 1954; 57: 285-300.
5. Zuckerman M, Steenkamp V, Stewart MJ,. Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique. J Clin Pathol 2002; 55: 676-679. (Pubitemid 34970089)
6. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB,. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171-1181.
7. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783. (Pubitemid 18034278)
8. Sebagh M, Debette M, Samuel D, Emile JF, Falissard B, Cailliez V, et al. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection. Hepatology 1999; 30: 1144-1150. (Pubitemid 29510851)
9. Eisenhauer T, Hartmann H, Rumpf KW, Helmchen U, Scheler F, Creutzfeldt W,. Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature. Digestion 1984; 30: 185-190. (Pubitemid 14032973)
10. Liaño F, Moreno A, Matesanz R, Teruel JL, Redondo C, García-Martín F, et al. Veno-occlusive disease of the liver in renal transplantation: is azathioprine the cause? Nephron 1989; 51: 509-516. (Pubitemid 19076375)
11. DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, Kanel GC,. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999; 29: 1779-1791. (Pubitemid 29247052)
12. DeLeve LD, Shulman HM, McDonald GB,. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27-42.
13. Sterneck M, Wiesner R, Ascher N, Roberts J, Ferrell L, Ludwig J, Lake J,. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991; 14: 806-810.
14. Buckley JA, Hutchins GM,. Association of hepatic veno-occlusive disease with the acquired immunodeficiency syndrome. Mod Pathol 1995; 8: 398-401.
15. Dworkin BM, Stahl RE, Giardina MA, Wormser GP, Weiss L, Jankowski R, Rosenthal WS,. The liver in acquired immunodeficiency syndrome: emphasis on patients with intravenous drug abuse. Am J Gastroenterol 1987; 82: 231-236. (Pubitemid 17047008)
16. Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR,. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant 1999; 24: 891-895. (Pubitemid 29500351)
17. Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs AK,. Veno occlusive disease: update on clinical management. World J Gastroenterol 2007; 13: 3918-3924. (Pubitemid 47272486)
18. Ben-Ari Z,. Ascites after transplantation-a mystery. Liver Transpl 2004; 10: 1221.
19. Blostein MD, Paltiel OB, Thibault A, Rybka WB,. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 439-443.
20. Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB,. Venooclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729-1736. (Pubitemid 23277325)
21. Bearman SI, Shuhart MC, Hinds MS, McDonald GB,. Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation. Blood 1992; 80: 2458-2462.
22. Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737-744. (Pubitemid 28355454)
23. Mor E, Pappo O, Bar-Nathan N, Shaharabani E, Shapira Z, Tur-Kaspa R, Ben-Ari Z,. Defibrotide for the treatment of veno-occlusive disease after liver transplantation. Transplantation 2001; 72: 1237-1240. (Pubitemid 33026601)
24. Boyer TD, Haskal ZJ,; for American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010; 51: 306.
25. Fried MW, Connaghan DG, Sharma S, Martin LG, Devine S, Holland K, et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 1996; 24: 588-591. (Pubitemid 26296002)
26. Lerut JP, Goffette P, Molle G, Roggen FM, Puttemans T, Brenard R, et al. Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation 1999; 68: 379-384. (Pubitemid 29384105)
27. Kitajima K, Vaillant JC, Charlotte F, Eyraud D, Hannoun L,. Intractable ascites without mechanical vascular obstruction after orthotopic liver transplantation: etiology and clinical outcome of sinusoidal obstruction syndrome. Clin Transplant 2010; 24: 139-148.
28. Senzolo M, Patch D, Cholongitas E, Triantos C, Marelli L, Stigliano R, et al. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt. Transplantation 2006; 82: 132-135. (Pubitemid 44296989)